<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Four-color fluorescence in-situ hybridization is useful to assist to distinguish early stage acral and cutaneous melanomas from dysplastic junctional or compound nevus.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Four-color fluorescence in-situ hybridization is useful to assist to distinguish early stage acral and cutaneous melanomas from dysplastic junctional or compound nevus." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216650/bin/13000_2020_937_Fig1_HTML.jpg"/> </div> <div class="text-side"> <h1>Four-color fluorescence in-situ hybridization is useful to assist to distinguish early stage acral and cutaneous melanomas from dysplastic junctional or compound nevus.</h1> <p>Case of melanoma in situ positive by fluorescence in-situ hybridization (FISH) detection. a Melanocytes proliferated successively or in nests in the basal layer of the epidermis (hematoxylin and eosin, H&amp;E staining), (b) high-power magnification showed moderate to severe atypia of the melanocytes(H&amp;E staining), (c-f) FISH images showed the (c) gain of CCND1 (green signals), (d) gain of RREB1 (red signals), and (f) loss of MYB (gold signals) relative to CEP6 (aqua signals). While the gain of RREB1(d) relative to CEP6 (e) was not observed</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32393283/" target="_blank">32393283</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>